All Insights

Artificial intelligence

New EU AI Act is poised to shape the future for life sciences in Europe

What is the extent of the sector's application of AI and the regulatory outlook following European Parliament approval?
Regulatory and compliance

European Parliament formally adopts Product Liability Directive

What changes and practical actions should businesses be considering?
International expansion and growth

Setting sail globally: launching internationally in an interconnected world

Launching a business internationally can be a game-changer but comes with its own set of challenges and considerations
Regulatory and compliance

UK government unveils draft procurement regulations for public sector bids

Authorities and suppliers will need to keep an eye on information published about procurements and resulting contracts
Life Sciences and Healthcare

Decision time for UK medical device regulation: diverge or converge with the EU?

The MHRA appears to be considering an approach for UK regulations that would broadly mirror the EU model
Life Sciences and Healthcare

Medication advertising in the digital age

The Generalitat of Catalonia has updated its guide to advertising medicines for human use with a focus on digital advertising
Intellectual property

What qualifies as a legitimate reason to object to parallel trade of medicines in Europe?

Trade mark owners are able to object to the parallel trade of medicines provided that there are legitimate reasons
Intellectual property

What are the patentability implications of deregulating gene editing in plants in the EU?

The European Parliament has voted to embrace more flexibility in the regulation of gene-edited plants but has proposed a ban
Life Sciences and Healthcare

Navigating Belgium's life sciences terrain: a strategic overview

Insights into regulations, trends, and strategic pathways for the pharmaceutical, medical device and food (supplement) industries
Life Sciences and Healthcare

EU assesses competition picture of the pharma sector

Commission reports to the Council on how EU antitrust and merger rules in the pharmaceutical sector have been enforced in
Regulatory and compliance

The UK Procurement Act 2023 brings new rules for frameworks and dynamic markets

The changes that are set to be introduced later this year could prove useful for both suppliers and authorities
Intellectual property

Updated EPO examination guidelines address AI, accelerated oppositions and antibody claims

The European Patent Office's new guidelines entered into force on 1 March